Depression, a global health problem with growing prevalence, brings serious impacts on the
daily life of patients. However, the antidepressants currently used in clinical are not perfectly …

The increasing prevalence of depression is a major societal burden. The etiology of
depression involves multiple mechanisms. Thus, the outcomes of the currently used …

Depression, recognized globally as a primary cause of disability, has its pathogenesis
closely related to neuroinflammation and neuronal damage. Arctiin (ARC), the major …

Depression, a mood disorder characterized by a persistent low mood and lack of enjoyment,
is considered the leading cause of non-fatal health losses worldwide. Neuroplasticity refers …

Sickness behaviour, a set of behavioural changes associated with neuroinflammation, is
expressed as decreased mobility and depressed behaviour. Activation of AMP‐activated …

Depression is a common neuropsychiatric disease that is characterized by long‐term,
repeated low mood, pain and despair, pessimism, and even suicidal tendencies. Increasing …

Berberine (BBR), a benzylisoquinoline alkaloid obtained from natural medicines such as
coptidis rhizoma, has a wide range of pharmacological activities such as protecting the …

Berberine has been found to improve diabetes-induced erectile dysfunction, but its role and
underlying molecular mechanism in hyperlipidemia-associated erectile dysfunction remain …

Stress has been linked to the development of irritable bowel syndrome (IBS), and various
methods have been explored to model IBS in combination with other stimuli. However, it …